Annik Bergeron

2014 White Paper on recent issues in bioanalysis: a full immersion in bioanalysis (Part 1--small molecules by LCMS).

Li Xue, Stacy Ho, Neil Spooner, 2014, Bioanalysis.

2014 White Paper on recent issues in bioanalysis: a full immersion in bioanalysis (Part 3 - LBA and immunogenicity).

Lindsay King, Roger Hayes, Surinder Kaur, 2014, Bioanalysis.

2014 White Paper on recent issues in bioanalysis: a full immersion in bioanalysis (Part 2 - hybrid LBA/LCMS, ELN & regulatory agencies' input).

Lindsay King, Stacy Ho, Roger Hayes, 2014, Bioanalysis.

"The most important thing is to ensure that the method used for sample ana lysis is selective, because you can be sure that the regulatory agencies will be selective when deciding if your submission is acceptable."

Fabio Garofolo, Natasha Savoie, Annik Bergeron, 2010 .

Impact of plasma and whole-blood anticoagulant counter ion choice on drug stability and matrix effects during bioanalysis.

Fabio Garofolo, Annik Bergeron, Mélanie Bergeron, 2009, Bioanalysis.

Pre-cut dried blood spot (PCDBS): an alternative to dried blood spot (DBS) technique to overcome hematocrit impact.

Fabio Garofolo, Annik Bergeron, Milton Furtado, 2011, Rapid communications in mass spectrometry : RCM.

How to manage having no incurred sample reanalysis evaluation failures.

Fabio Garofolo, Natasha Savoie, Annik Bergeron, 2011, Bioanalysis.